A tissue plasminogen activator administered to?

A tissue plasminogen activator (tPA) is administered to dissolve blood clots in conditions such as acute ischemic stroke, myocardial infarction, and pulmonary embolism. By converting plasminogen to plasmin, tPA helps restore blood flow, minimizing tissue damage and improving outcomes. Timely administration is crucial, as it is most effective when given within a few hours of symptom onset. However, it carries risks, such as bleeding, and is contraindicated in certain patients.